Evidence map›Paper›PMID 30647464›Full record

ReviewJournal of human hypertension2019

Labile hypertension: a new disease or a variability phenomenon?

Elias Sanidas, Charalampos Grassos, Dimitrios P Papadopoulos, Maria Velliou, Kostas Tsioufis, Marina Mantzourani, Despoina Perrea, Dimitrios Iliopoulos, John Barbetseas, Vasilios Papademetriou

Abstract readReview
PubMed Publisher
In one paragraph

Review in Journal of human hypertension, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Estimating cardiovascular health gains from eradicating indoor cold in Australia.Environmental health : a global access science source · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elias SanidasDepartment of Cardiology, Hypertension Excellence Centre - ESH, LAIKO General Hospital, Athens, Greece. easanidas@yahoo.gr.
Charalampos GrassosDepartment of Cardiology, Hypertension Excellence Centre - ESH, KAT General Hospital, Athens, Greece.
Dimitrios P PapadopoulosDepartment of Cardiology, Hypertension Excellence Centre - ESH, LAIKO General Hospital, Athens, Greece.
Maria VelliouDepartment of Cardiology, Hypertension Excellence Centre - ESH, LAIKO General Hospital, Athens, Greece.
Kostas TsioufisFirst Department of Cardiology, Hippokration Hospital, University of Athens, Medical School, Athens, Greece.
Marina MantzouraniFirst Department of Internal Medicine, LAIKO General Hospital, University of Athens, Medical School, Athens, Greece.
Despoina PerreaLaboratory of Experimental Surgery and Surgical Research "N.S. Christeas" University of Athens, Medical School, Athens, Greece.
Dimitrios IliopoulosLaboratory of Experimental Surgery and Surgical Research "N.S. Christeas" University of Athens, Medical School, Athens, Greece.
John BarbetseasDepartment of Cardiology, Hypertension Excellence Centre - ESH, LAIKO General Hospital, Athens, Greece.
Vasilios PapademetriouHypertension and Cardiovascular Research Clinic, Veterans Affairs and Georgetown University Medical Centers, Washington, DC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Blood pressure (BP) is a physiological parameter with short- and long-term variability caused by complex interactions between intrinsic cardiovascular (CV) mechanisms and extrinsic environmental and behavioral factors. Available evidence suggests that not only mean BP values are important, but also BP variability (BPV) might contribute to CV events. Labile hypertension (HTN) is referred to sudden rises in BP and it seems to be linked with unfavorable outcomes. The aim of this article was to review and summarize recent evidence on BPV phenomenon, unraveling the labile HTN concept along with the prognostic value of these conditions.

Indexed as

Blood PressureCircadian RhythmGlomerular Filtration RateHumansHypertensionPrognosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.